QUÉBEC CITY, Sept. 26, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX:AEZ) (the"Company") today announced that its Senior Vice
President and CFO, Dennis Turpin, CPA CA, will be presenting a corporate
overview at BioContact on Wednesday, October 3, 2012, at 2 pm (Eastern), in
the Grande-Allée Room of the Château Laurier Hotel in Québec City, Canada.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development company
currently investigating treatments for various unmet medical needs. The
Company's pipeline encompasses compounds at all stages of development, from
drug discovery through to marketed products. For more information please visit
Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator
(418) 652-8525 ext. 265 firstname.lastname@example.org
Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext.
SOURCE: AETERNA ZENTARIS INC.
To view this news release in HTML formatting, please use the following URL:
CO: AETERNA ZENTARIS INC.
NI: BTC HEA MTC MED
-0- Sep/26/2012 11:30 GMT
Press spacebar to pause and continue. Press esc to stop.